Target intelligence / Profile preview

Sad1 and UNC84 domain containing protein 2 (SUN2)

Target
SUN2
Molecular classification
Other, Inner nuclear membrane protein, Nuclear envelope protein, LINC (Linker of Nucleoskeleton and Cytoskeleton) complex component
01

Overview

Sad1 and UNC84 domain containing protein 2 (SUN2) is an inner nuclear membrane (INM) protein and a component of the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex[2][3][5]. SUN2 spans the inner nuclear membrane and interacts in the perinuclear space with KASH-domain proteins (such as Nesprins) to physically connect the nucleoskeleton to the cytoskeleton[3][5]. SUN2 forms trimers via its coiled-coil domains to bind KASH proteins and is involved in mechanotransduction, positioning of the nucleus, and maintenance of nuclear shape[3]. Its regulated degradation involves ubiquitination by the SCF^βTrCP^ ubiquitin ligase, extraction from the membrane by the p97 ATPase, and proteasomal degradation, which is tightly controlled by Casein Kinase 2 (CK2) and the phosphatase CTDNEP1[1][2]. Disruption or accumulation of non-degradable SUN2 causes severe nuclear architecture defects, impairs DNA damage repair, and can result in chromosomal instability during mitosis[1][2]. Mutations in SUN2 have been linked to muscular dystrophy and other nuclear envelope disorders[3][5]. To date, SUN2 is not recognized as a direct therapeutic drug target or receptor, and there are no known drugs specifically targeting SUN2.

Other names
SUN domain-containing protein 2SUN2FRIGGKIAA0668RAB5IPUNC84BRab5IPProtein unc-84 homolog BRab5-interacting proteinSad1/unc-84 protein-like 2rab5IPSad1 unc-84 domain protein 2nuclear envelope protein
02

Biological functions

Maintenance of nuclear architectureNuclear-cytoskeletal linkageMechanotransductionRegulation of nuclear envelope (NE) morphologyAssembly/disassembly of the nuclear envelope during mitosisDouble-strand DNA break repair
03

Disease associations

Muscular dystrophy and related myopathies (due to mutations in SUN2)Potential role in other nuclear envelopathies/disorders affecting nuclear morphology or DNA repair
04

Safety considerations

No direct safety concerns reported as a therapeutic target; disruption may affect nuclear integrity, cell division, and genome stability[1][2][5]
05

Biomarkers

γH2AX (Ser139-phosphorylated histone H2AX, for DNA damage in studies involving SUN2 mutations or dysfunction)[1][2]

Beyond the preview

Go deeper on Sad1 and UNC84 domain containing protein 2 (SUN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sad1 and UNC84 domain containing protein 2 (SUN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call